AC
RARE icon

AXQ Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History

AXQ Capital’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13M Sell
33,800
-62,377
-65% -$1.55M 0.12% 255
2026
Q1 		$2.01M Buy
+96,177
New +$2.17M 0.26% 106
2025
Q2 		– Sell
-12,346
Closed -$447K – 742
2025
Q1 		$447K Sell
12,346
-10,731
-47% -$446K 0.18% 215
2024
Q4 		$971K Buy
+23,077
New +$1.14M 0.44% 65
2024
Q2 		– Sell
-14,600
Closed -$682K – 675
2024
Q1 		$682K Buy
+14,600
New +$689K 0.16% 218

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

AXQ Capital's RARE Position: Q2 2026 in Review

AXQ Capital reduced its Ultragenyx Pharmaceutical (RARE) stake by 65% in Q2 2026, selling an estimated $1.55M and leaving 33,800 shares worth $1.13M. The position accounts for 0.12% of the portfolio, ranked #255.

AXQ Capital first reported a position in RARE in Q1 2024 and has held it in 5 quarters since. The position peaked at $2.01M in Q1 2026. 311 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • AXQ Capital held 33,800 shares of Ultragenyx Pharmaceutical worth $1.13M as of Q2 2026.
  • AXQ Capital sold 62,377 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $1.55M.
  • Ultragenyx Pharmaceutical made up 0.12% of AXQ Capital's portfolio in Q2 2026, its #255 holding.
  • AXQ Capital first reported a position in Ultragenyx Pharmaceutical in Q1 2024 and has held it in 5 quarters since.
  • AXQ Capital's Ultragenyx Pharmaceutical position peaked at $2.01M in Q1 2026.
  • 311 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.